Monitoring mitochondrial metabolisms in irradiated human cancer cells with (99m)Tc-MIBI.

Cationic hexakis(2-methoxyisobutylisonitrile)-technetium-99m ((99m)Tc-MIBI), an agent for scintigraphic detection and imaging of tumors, accumulates in mitochondria of various cells and tissues of high mitochondrial metabolic activity. To monitor the mitochondrial metabolisms of human cancer cells exposed to ionizing radiation, uptake of (99m)Tc-MIBI in an irradiated human lung cancer cell line (A549) was measured at 1-12 h following 0-9 Gy irradiation in vitro. Mitochondrial membrane potential, an index of mitochondrial activity, was also determined by flow cytometry with 3,3'-dihexyloxacarbocyanine (DiOC6(3)).

99mTc-MIBI scintigraphy for early detection of locally recurrent non-small cell lung cancer treated with definitive radiation therapy.

After radiation therapy of lung cancer, a dense fibrotic shadow develops in the irradiated lung. Owing to this fibrosis, early detection of local recurrence after treatment is sometimes difficult even when using computed tomography (CT) and magnetic resonance imaging. We investigated the diagnostic accuracy of technetium-99m hexakis 2-methoxyisobutylisonitrile ((99m)Tc-MIBI) scintigraphy for the detection of recurrent lung cancer following definitive radiation therapy.